Should I Buy QTRX? QTRX 2026 Analysis

Should You Buy Quanterix Corp (QTRX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

6.320

1 Day change

-2.02%

52 Week Range

8.880

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now. QTRX is in a weakening short-term trend (bearish MACD expansion, price slipping toward lower supports) and there are no proprietary buy signals or fresh news catalysts to justify an impatient entry today. While options positioning is call-heavy and could support a bounce, the extremely elevated implied volatility and deteriorating profitability/margins make the risk/reward unattractive for an immediate buy.

Technical Analysis

Price/Trend: QTRX is down ~4.93% today to 6.35 (pre-market -1.94%), underperforming the S&P 500 (-0.27%). Momentum: MACD histogram is negative (-0.0869) and negatively expanding, which supports a continuing bearish/weak momentum regime. RSI(6)=35.789 is leaning toward oversold but not deeply oversold, implying downside can still persist before a clean mean-reversion signal appears. Moving averages are converging, suggesting consolidation/indecision, but the MACD indicates this consolidation is resolving bearishly. Levels: Pivot 7.11 is well above spot (overhead supply). Near-term support is S1 6.417 (already slightly broken) and S2 5.988 (next downside magnet). Upside resistance levels are R1 7.803 and R2 8.232—meaning a bounce would first need to reclaim ~6.42–7.11 to improve the setup.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment/Positioning: Put/call ratios are extremely low (OI PCR 0.14; Volume PCR 0.08), indicating strong call skew (bullish/speculative positioning).

Volatility: Implied vol (30d) is very elevated at ~201.54 versus historical vol ~57.38, with IV percentile 98 and IV rank ~84.98—options are pricing unusually large moves, implying high uncertainty and expensive premiums.

Flow/Activity: Today’s options volume is low (26 contracts) but shows a large spike versus the 30-day average (43.33), suggesting sporadic speculative interest rather than consistent accumulation.

Takeaway: Options lean bullish, but the extreme IV points to unstable price action and less favorable odds for a straightforward ‘buy stock now’ entry.

Technical Summary

Sell

Buy

Positive Catalysts

Analyst price target raised (Canaccord to $8 from $
suggests improved sector/coverage outlook into
Revenue growth in the latest quarter (2025/Q3 +12.34% YoY) shows top-line momentum.
Call-skewed options positioning (very low put/call ratios) can support a short-term bounce if selling pressure exhausts near S2 (~5.99).

Neutral/Negative Catalysts

Technical momentum is bearish (MACD negative and worsening) and price is breaking below near support (S1 6.417), increasing odds of a test of S2 (5.988).
Profitability is deteriorating: net loss expanded materially YoY and gross margin fell sharply.
No news/events in the past week—no clear near-term catalyst to reverse the tape.
Extremely high implied volatility suggests elevated risk of sharp downside moves and unstable price action.

Financial Performance

Latest quarter: 2025/Q3. Revenue increased to $40.233M (+12.34% YoY), indicating continued sales growth. However, profitability worsened: net income was -$33.517M (loss expanded significantly YoY) and EPS was -$0.73 (loss widened). Gross margin dropped to 42.77% (-23.99% YoY), a notable deterioration that pressures the path to breakeven. Overall: top-line growth is positive, but margin compression and a larger loss are near-term negatives.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent change (2025-12-22): Canaccord raised the price target to $8 (from $5) but maintained a Hold rating, citing continued sector momentum into 2026. Wall Street-style view: Pros—improving sector backdrop and revenue growth; higher PT implies upside from current levels if execution improves. Cons—Hold rating reflects uncertainty, and the company’s margin and loss trajectory undermine conviction for aggressive buying at the current moment. Ownership/flows: Hedge funds and insiders are neutral (no significant recent trends). Politicians/Congress: No recent congress trading data available (no reported influential buying/selling signal).

2 Analyst Rating

Wall Street analysts forecast QTRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for QTRX is 7.5 USD with a low forecast of 7 USD and a high forecast of 8 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

2 Hold

0 Sell

Hold

Current: 6.450

Low

Averages

7.5

High

Current: 6.450

Low

Averages

7.5

High

Canaccord

Hold

maintain

$5 -> $8

AI Analysis

2025-12-22

Reason

Canaccord

Price Target

$5 -> $8

AI Analysis

2025-12-22

maintain

Hold

Reason

Canaccord raised the firm's price target on Quanterix to $8 from $5 and keeps a Hold rating on the shares. The firm previewed its life science tools and diagnostics covereage and believes momentum in the sector which began in the second half of this year, can be maintained in 2026.

Canaccord

Buy -> Hold

downgrade

$12 -> $5

2025-08-11

Reason

Canaccord

Price Target

$12 -> $5

2025-08-11

downgrade

Buy -> Hold

Reason

Canaccord downgraded Quanterix to Hold from Buy with a price target of $5, down from $12. following the Q2 miss. The firm cites a lack of near-term visibility and catalysts to move the shares higher for the downgrade. Quanterix's results were impacted by increasing headwinds in biopharma and continued National Institutes of Health funding uncertainty, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for QTRX

Unlock Now

QTRX Should I Buy

QTRX Should I Buy

Should You Buy Quanterix Corp (QTRX) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch